- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05010239
The Immediate Effect of Mindfulness-Based Supportive Therapy on Palliating Suffering in Palliative Care Cancer Patients
The Immediate Effect of Mindfulness-Based Supportive Therapy (MBST) vs Supportive Listening on Palliating Suffering in Palliative Care Cancer Patients: A Randomised Controlled Trial
Study Overview
Status
Intervention / Treatment
Detailed Description
This study was conducted in the University Malaya Medical Centre. The study design was a parallel-group, single-blinded, randomized controlled trial. The trial will be registered at the Clinical Trials registry and was conducted in accordance to the Declaration of Helsinki. The investigators recruited patients by screening patients under the care of the palliative care team at University Malaya Medical Centre. Patients fulfilling the inclusion and exclusion criteria will be approached and included in the study if give informed consent to participate.
Inclusion criteria:
- Stage III and IV cancer patients aged 18 years and above
- The overall suffering score of 4/10 and above based on The Suffering Pictogram
Exclusion criteria:
- Patients who are confused based on The Confusion Assessment scoring
- Patients who are non-communicative verbally
- Patients with psychiatric illness
Patients who were eligible were informed about the nature of the study. The study was voluntary and patients could withdraw from the study at any time. Patients who were interested to participate was randomly allocated to either the intervention group (MBST) or the control group (supportive listening) based on computer generated random numbers. Allocation concealment will be performed using sealed envelopes.
Patients in the intervention group received a 30-minute MBST session by a palliative care physician trained in mindfulness practice. The MBST consisted of a session that involvesd interviewing patients with open-ended questions on suffering experiences. During the session, the practitioner practiced mindful breathing simultaneously while listening to patients. The practitioner acknowledged the distress of patients when it was appropriate, but without losing their attention on mindful breathing.
Patients in the control group received a 30-minute supportive listening session by a palliative care physician who has no experience in mindfulness practice. The session involves interviewing patients with the same open-ended questions on suffering experiences. The practitioner acknowledged the distress of patients when it was appropriate. Outcomes will be measured at baseline and at minute 30.
Primary outcomes (patients): Suffering was measured using the Suffering Pictogram. It is a brief and validated instrument used to measure the experience of suffering in palliative care. Patients were required to rate overall suffering at the centre of the pictogram with a numerical scale of 0 to 10 (0 = no suffering, 10 = worst possible suffering). The pictogram contains eight items rated on a Likert scale - discomfort, worry, fear, anger, sadness, hopelessness, difficulty in acceptance and emptiness. The total suffering score of the eight items ranged from 0 to 32, with higher score reflecting more suffering.
Psychological distress was examined using the Hospital Anxiety and Depression Scale (HADS). The HADS consisted of 14 items rated on a Likert scale yielding a score of total score (0-42), an anxiety score (0-21) and a depression score (0-21), with higher score reflecting higher distress.
Quality of life (QOL) was assessed by the Functional Assessment of Chronic Illness Therapy (FACIT-Sp). It contained 39 items (range from 0 to 4, with higher scores reflecting higher QOL) forming an overall total score and five subscales scores: physical, social, emotional, functional and spiritual.
Patient's perception of practitioner empathic engagement was measured with the Jefferson Scale of Patient's Perceptions of Physician Empathy. It was a 5-item instrument (range from 1 to 5, with higher scores reflecting a greater degree of physician's empathy).
Secondary outcomes (practitioners): Secondary outcomes were measured by the Perceived Stress Scale (PSS) and the Frieburg Mindfulness Inventory (FMI).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Selangor
-
Kuala Lumpur, Selangor, Malaysia, 50603
- University Malaya Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Stage III and IV cancer patients aged 18 years and above
- The overall suffering score of 4/10 and above based on The Suffering Pictogram
Exclusion Criteria:
- Patients who are confused based on The Confusion Assessment scoring (CAM)
- Patients who are non-communicative verbally
- Patients with psychiatric illness
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Intervention group
Patients in the intervention group will receive a 30-minute MBST session by a palliative care physician trained in mindfulness practice.
The MBST consists of a session that involves interviewing patients with open-ended questions on suffering experiences.
During the session, the practitioner will practice mindful breathing simultaneously while listening to patients.
The practitioner will acknowledge the distress of patients when it is appropriate, but without losing their attention on mindful breathing.
Outcomes will be measured at baseline and at minute 30.
|
The MBST consists of a session that involves interviewing patients with open-ended questions on suffering experiences.
During the session, the practitioner will practice mindful breathing simultaneously while listening to patients.
The practitioner will acknowledge the distress of patients when it is appropriate, but without losing their attention on mindful breathing.
|
|
Placebo Comparator: Control group
Patients in the control group will receive a 30-minute supportive listening session by a palliative care physician who has no experience in mindfulness practice.
The session involves interviewing patients with the same open-ended questions on suffering experiences.
The practitioner will acknowledge the distress of patients when it is appropriate.
Outcomes will be measured at baseline and at minute 30.
|
Patients in the control group will receive a 30-minute supportive listening session by a palliative care physician who has no experience in mindfulness practice.
The session involves interviewing patients with the same open-ended questions on suffering experiences.
The practitioner will acknowledge the distress of patients when it is appropriate.
Outcomes will be measured at baseline and at minute 30.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Suffering measured using the Suffering Pictogram.
Time Frame: 30-minute
|
Suffering pictogram is in numerical scale of 0 to 10 (0 = no suffering, 10 = worst possible suffering).
The pictogram contains eight items rated on a Likert scale - discomfort, worry, fear, anger, sadness, hopelessness, difficulty in acceptance and emptiness.
The total suffering score of the eight items ranges from 0 to 32, with higher score reflecting more suffering.
|
30-minute
|
|
Psychological distress examined using the Hospital Anxiety and Depression Scale.
Time Frame: 30-minute
|
Hospital Anxiety and Depression Scale consists of 14 items rated on a Likert scale yielding a score of total score (0-42), an anxiety score (0-21) and a depression score (0-21), with higher score reflecting higher distress.
|
30-minute
|
|
Quality of life assessed by the Functional Assessment of Chronic Illness Therapy.
Time Frame: 30-minute
|
Functional Assessment of Chronic Illness Therapy, contains 39 items (range from 0 to 4, with higher scores reflecting higher quality of life) forming an overall total score and five subscales scores: physical, social, emotional, functional and spiritual.
|
30-minute
|
|
Patient's perception of practitioner empathic engagement measured with the Jefferson Scale of Patient's Perceptions of Physician Empathy
Time Frame: 30-minute
|
Jefferson Scale of Patient's Perceptions of Physician Empathy is a 5-item instrument (range from 1 to 5, with higher scores reflecting a greater degree of physician's empathy).
|
30-minute
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Perception of stress measured by Perceived Stress Scale
Time Frame: 30-minute
|
Perceived Stress Scale has 10 items, each range 0 - never to 4 - very often.
The total score is 40, with higher score indicates more perceive stress.
|
30-minute
|
|
Mindfulness measured by Frieburg Mindfulness Inventory
Time Frame: 30-minute
|
Frieburg Mindfulness Inventory has 14 items, from 1 (rarely) to 4 (always).
The higher the total score, the higher the mindfulness.
|
30-minute
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Chee-Shee Chai, MD, Faculty of Medicine and Health Science, University Malaysia Sarawak
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202089-8970
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Palleon Pharmaceuticals, Inc.CompletedMelanoma | Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | NSCLC | Non Small Cell Lung Cancer | Bladder Cancer | Colon Cancer | Urothelial Cancer | Oncology | CRC | Esophagogastric Junction Cancer | EGJUnited States
-
University of California, San DiegoWithdrawnCervical Cancer | Cervical Cancer Stage | Cervical Cancer Stage IB2 | Cervical Cancer Stage IB1 | Cervical Cancer Stage I | Cervical Cancer Stage IB | Cervical Cancer Stage II | Cervical Cancer Stage IIa | Cervical Cancer, Stage IIB | Cervical Cancer, Stage III | Cervical Cancer Stage IIIB | Cervical Cancer... and other conditionsUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
Clinical Trials on 30-minute Mindfulness-Based Supportive Therapy
-
Massachusetts General HospitalCompletedBipolar DisorderUnited States
-
Canadian Breast Cancer Research AllianceBritish Columbia Cancer AgencyUnknown
-
University of Sao Paulo General HospitalCompletedGeneralized Anxiety DisorderBrazil
-
VA Office of Research and DevelopmentCompletedParkinson's DiseaseUnited States
-
Instituto de Investigación Hospital Universitario...Completed
-
Firat UniversityNot yet recruitingHeart Failure | Heart Failure - NYHA II - IV
-
Florida State UniversityCompletedPain | Acute PainUnited States
-
The Hong Kong Polytechnic UniversityCompletedElderly | Mood | Music Therapy | Mindfulness | BlindHong Kong
-
Vancouver Coastal HealthRecruitingSituational Erectile DysfunctionCanada
-
University of WarsawCompletedModerate Depressive Episode | Mild Depressive EpisodePoland